HAMP

Across TCGA pan-cancer cohorts, HAMP mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated HAMP data layer compared with 15 for mass-spec protein and 1 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher HAMP mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated HAMP expression acts as an unfavorable survival marker, although some lineages such as CCRCC and LSCC show a favorable association.

CCRCC, LSCC, and LUAD are the cancer types where HAMP mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Tertile	All	0.924	0.578	.025	4	view →
LSCC	DFS	Tertile	II,III,IV	0.887	0.186	.024	3	view →
LUAD	OS	Median	II,III,IV	0.794	1.000	.034	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

HAMP–CCRCC (DFS)

Open the CCRCC breakdown →